Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04435977
Title Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma (Immunocabo)
Acronym Immunocabo
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Clinico Humanitas
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.